SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Fennec Pharma Q3 product sales rise 56% on PEDMARK demand

Fennec Pharma Q3 product sales rise 56% on PEDMARK demand Overview US specialty pharma firm's Q3 pro

FENCKURASRRK

Related stories